Berkshire Hathaway Inc. (BERK34Q)

IREN

TIPS KOSS

SNDK RGBPP EPAM

NXGB RGBP JACK

Very interesting. Something else always missing from the L Plll trial was any follow up article explaining the promise of DC’s passing the BBB. 🤷‍♀️


https://www.clinicaltrialvanguard.com/article/trend-watch/checkpoint-inhibitors-are-failing-recurrent-gbm-this-phase-1-

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference® (AAIC®) 2026July 12, 2026 11:15 AM
PR Newswire (US)

CNMD FEIM AI

ALGT TPTW

EDGM

If the crowdfunding thing ever happens, I hope this crew gives Electrome huge piles of money. I want to see what Electrome can do WITH funding and WITHOUT Mayer.

There's no way to predict the future, but I think Electrome is going to dry up and blow away by the end of the year. If I'm

CNMD

CLNV

CENX

NEGG

1.2.9.12
Good Luck Everyone!!

SKYW

It would be nice if information was provided before 2027. Annual reporting isn't often enough.

ALGT

Looking forward to the filing this week. Expecting some positive results in it! GO TO THE MOON DBMM.

STGW

ONDS

You should read deeper than just headlines when you do "research." FACT: The worldwide market for the failed Lenz for all indications is exactly ZERO (0).

FACTS: Lenz has never failed any test in its targeted patient population. The government wanted it to fail one so they recruite

69 THIS AM

NEN

ARIS